Rational cotargeting of HDAC6 and BET proteins yields synergistic antimyeloma activity
Jennifer S. Carew(University of Arizona), Steffan T. Nawrocki(University of Arizona), Faiz Anwer(Cleveland Clinic), Valeria Visconte(Cleveland Clinic), Kevin R. Kelly(Keck Hospital of USC), Claudia M. Espitia(The University of Texas System), Weiguo Zhao(Audie L. Murphy Memorial VA Hospital)
Cited by 26
Related Papers
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
|Cancer Letters|2008|426
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
|Clinical Cancer Research|2015|355